Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001055726-25-000039
Filing Date
2025-05-21
Accepted
2025-05-21 16:58:26
Documents
1
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1747861099.html 4  
1 FORM 4 wk-form4_1747861099.xml 4 5178
  Complete submission text file 0001055726-25-000039.txt   7003
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Issuer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INOVIO PHARMACEUTICALS, INC. 660 W. GERMANTOWN PIKE, SUITE 110 PLYMOUTH MEETING PA 19462
Business Address
Miller Ann Calby (Reporting) CIK: 0001771423 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14888 | Film No.: 25973798